Vanguard Group Discloses Position in Spire Healthcare

The Vanguard Group, Inc. has released its Form 8.3 disclosure concerning its stake in Spire Healthcare Group PLC. The form was submitted on October 5, 2026, and pertains to positions held as of October 2, 2026. Vanguard owns 14,443,504 ordinary shares in Spire, representing a 3.59% interest in the company.

According to the document, no cash-settled or stock-settled derivatives related to Spire Healthcare are held by Vanguard. The disclosure does not include any indemnities or option arrangements that could influence dealings. Furthermore, there are no agreements regarding voting rights associated with any options or derivatives.

The filing indicates a recent transaction where Vanguard sold 1,076 shares of Spire at a price of 2.47 GBP per unit. No additional positions or rights to subscribe for new securities are reported in this disclosure.